Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with G
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q3 2024 | GLYCERIN | ORAL | CAPSULE, GELATIN COATED | 3.37 mg | Deletion | ||
| Q3 2024 | GLYCERYL MONO- AND DICAPRYLOCAPRATE | ORAL | CAPSULE, DELAYED RELEASE | 4.07 mg | 24mg | Deletion | |
| Q3 2024 | GLYCERYL MONO- AND DICAPRYLOCAPRATE | ORAL | CAPSULE, GELATIN COATED | 62.20 mg | Deletion | ||
| Q3 2024 | GLYCERYL MONO- AND DICAPRYLOCAPRATE | ORAL | TABLET | 1.30 mg | Deletion | ||
| Q3 2024 | GLYCERYL MONO- AND DIPALMITOSTEARATE | ORAL | CAPSULE | 2.69 mg | 16mg | Deletion | |
| Q2 2024 | GLYCERIN | OPHTHALMIC | SUSPENSION | 2.50 %w/v | MDE Replacement | ||
| Q3 2024 | GLYCERIN | OPHTHALMIC | SUSPENSION | 58mg | MDE Replacement | ||
| Q2 2024 | GLYCERYL ISOSTEARATE | VAGINAL | CREAM | 2.70 %w/w | MDE Replacement | ||
| Q3 2024 | GLYCERYL ISOSTEARATE | VAGINAL | CREAM | 135mg | MDE Replacement | ||
| Q2 2024 | GUAR GUM | ORAL | POWDER, FOR SUSPENSION | 12.50 mg/ 5.00 ml | MDE Replacement | ||
| Q3 2024 | GUAR GUM | ORAL | POWDER, FOR SUSPENSION | 100mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024